CC
FMI

Cannell & Co’s Foundation Medicine, Inc. FMI Stock Holding History

Cannell & Co’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-33,085
Closed -$1.33M – 259
2017
Q3 		$1.33M Buy
33,085
+5,600
+20% +$216K 0.05% 158
2017
Q2 		$1.09M Buy
+27,485
New +$1.01M 0.04% 163
2016
Q4 		– Sell
-9,485
Closed -$221K – 269
2016
Q3 		$221K Buy
+9,485
New +$215K 0.01% 247
2016
Q1 		– Sell
-13,035
Closed -$275K – 273
2015
Q4 		$275K Sell
13,035
-2,875
-18% -$55.4K 0.01% 241
2015
Q3 		$294K Buy
+15,910
New +$397K 0.01% 232
2015
Q1 		– Sell
-16,860
Closed -$375K – 280
2014
Q4 		$375K Sell
16,860
-3,150
-16% -$72.7K 0.01% 218
2014
Q3 		$379K Buy
20,010
+8,150
+69% +$194K 0.01% 216
2014
Q2 		$320K Buy
+11,860
New +$301K 0.01% 233

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HCM
Hitchwood Capital Management New York $184M AUM 3.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Cannell & Co's FMI Position: Q4 2017 in Review

Cannell & Co sold out of Foundation Medicine, Inc. (FMI) in Q4 2017, closing a stake of 33,085 shares — an estimated $1.33M sold.

Cannell & Co first reported a position in FMI in Q2 2014 and held it in 8 quarters. The position peaked at $1.33M in Q3 2017. 127 funds tracked by Wall St. Rank hold FMI as of Q4 2017.

  • Cannell & Co reported no remaining Foundation Medicine, Inc. position as of Q4 2017 after selling out during the quarter.
  • Cannell & Co sold 33,085 Foundation Medicine, Inc. shares in Q4 2017, an estimated $1.33M.
  • Cannell & Co first reported a position in Foundation Medicine, Inc. in Q2 2014 and held it in 8 quarters.
  • Cannell & Co's Foundation Medicine, Inc. position peaked at $1.33M in Q3 2017.
  • 127 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q4 2017.

Based on Cannell & Co's 13F filing for Q4 2017, filed 13 Feb 2018.